» Articles » PMID: 27155756

Nationwide Increase in Hospitalizations for Heroin-related Soft Tissue Infections: Associations with Structural Market Conditions

Overview
Publisher Elsevier
Specialty Psychiatry
Date 2016 May 9
PMID 27155756
Citations 73
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: Little is known about trends in national rates of injection-related skin and soft tissue infections (SSTI) and their relationship to the structural risk environment for heroin users. Use of Mexican-sourced "Black Tar" heroin, predominant in western US states, may have greater risk for SSTI compared with eastern US powder heroin (Colombian-sourced) due to its association with non-intravenous injection or from possible contamination.

Methods: Using nationally representative hospital admissions data from the Nationwide Inpatient Sample and heroin price and purity data from the Drug Enforcement Administration, we looked at rates of hospital admissions for opiate-related SSTI (O-SSTI) between 1993 and 2010. Regression analyses examined associations between O-SSTI and heroin source, form and price.

Results: Hospitalization rates of O-SSTI doubled from 4 to 9 per 100,000 nationally between 1993 and 2010; the increase concentrated among individuals aged 20-40. Heroin market features were strongly associated with changes in the rate of SSTI. Each $100 increase in yearly heroin price-per-gram-pure was associated with a 3% decrease in the rate of heroin-related SSTI admissions. Mexican-sourced-heroin-dominant cities had twice the rate of O-SSTI compared to Colombian-sourced-heroin-dominant cities.

Discussion: Heroin-related SSTI are increasing and structural factors, including heroin price and source-form, are associated with higher rates of SSTI hospital admissions. Clinical and harm reduction efforts should educate heroin users on local risk factors, e.g., heroin type, promote vein health strategies and provide culturally sensitive treatment services for persons suffering with SSTI.

Citing Articles

Addiction consult service involvement in PrEP and PEP delivery for patients who inject drugs admitted to an urban essential hospital.

Rozansky H, Christine P, Younkin M, Fox J, Weinstein Z, Suarez S Addict Sci Clin Pract. 2024; 19(1):77.

PMID: 39497126 PMC: 11533369. DOI: 10.1186/s13722-024-00502-5.


A hand-washing community-based educational intervention to reduce abscess incidence among people who inject drugs: a cluster randomised controlled clinical trial protocol (the HAWA study protocol).

Balhan L, Aubert M, Lacoux C, Grau N, Levy J, Stefanowski M BMC Public Health. 2024; 24(1):2858.

PMID: 39420312 PMC: 11484296. DOI: 10.1186/s12889-024-20299-x.


Social determinants of injection drug use-associated bacterial infections and treatment outcomes: systematic review and meta-analysis.

Brothers T, Lewer D, Bonn M, Kim I, Comeau E, Figgatt M medRxiv. 2024; .

PMID: 39398993 PMC: 11469356. DOI: 10.1101/2024.09.20.24313898.


Racialized environments and syringe services program implementation: County-level factors.

Bluthenthal R, Humphrey J, Strack C, Wenger L, LaKosky P, Patel S Drug Alcohol Depend. 2024; 263:112430.

PMID: 39216198 PMC: 11409812. DOI: 10.1016/j.drugalcdep.2024.112430.


Use of Syringe Service Programs in Rural vs Urban Maine: A Harm-Reduction Study.

Miller L, Murray K, Branch E, Thakarar K J Maine Med Cent. 2024; 6(1).

PMID: 39118865 PMC: 11309026. DOI: 10.46804/2641-2225.1153.


References
1.
Passaro D, Werner S, McGee J, Mac Kenzie W, Vugia D . Wound botulism associated with black tar heroin among injecting drug users. JAMA. 1998; 279(11):859-63. DOI: 10.1001/jama.279.11.859. View

2.
Mars S, Bourgois P, Karandinos G, Montero F, Ciccarone D . "Every 'never' I ever said came true": transitions from opioid pills to heroin injecting. Int J Drug Policy. 2013; 25(2):257-66. PMC: 3961517. DOI: 10.1016/j.drugpo.2013.10.004. View

3.
Caulkins J . Price and purity analysis for illicit drug: data and conceptual issues. Drug Alcohol Depend. 2006; 90 Suppl 1:S61-8. DOI: 10.1016/j.drugalcdep.2006.08.014. View

4.
Small W, Wood E, Lloyd-Smith E, Tyndall M, Kerr T . Accessing care for injection-related infections through a medically supervised injecting facility: a qualitative study. Drug Alcohol Depend. 2008; 98(1-2):159-62. DOI: 10.1016/j.drugalcdep.2008.05.014. View

5.
Robinowitz N, Smith M, Serio-Chapman C, Chaulk P, Johnson K . Wounds on wheels: implementing a specialized wound clinic within an established syringe exchange program in Baltimore, Maryland. Am J Public Health. 2014; 104(11):2057-9. PMC: 4202967. DOI: 10.2105/AJPH.2014.302111. View